Psychotic Disorders - Guatemala | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$7.63m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.24%, resulting in a market volume of US$7.72m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$37.46 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Guatemala has been experiencing significant growth in recent years, driven by a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in Guatemala have shifted towards a greater awareness and acceptance of mental health issues, including psychotic disorders. There is a growing recognition of the importance of early diagnosis and treatment, leading to an increased demand for medications and therapies for psychotic disorders. Additionally, there is a preference for personalized treatment plans that take into account the individual needs and circumstances of patients.Trends in the market also contribute to the growth of the Psychotic Disorders market in Guatemala. One key trend is the increasing availability and accessibility of mental health services. This is partly due to the efforts of the government and healthcare organizations to improve mental health infrastructure and increase funding for mental health programs. As a result, more people are able to access the necessary treatments and medications for psychotic disorders.Another trend is the development of new and innovative treatment options for psychotic disorders. Pharmaceutical companies are investing in research and development to create more effective and targeted medications. This has led to the introduction of new drugs that have shown promising results in treating psychotic disorders. These advancements in treatment options have further fueled the growth of the market.Local special circumstances in Guatemala also contribute to the development of the Psychotic Disorders market. The country has a high prevalence of mental health disorders, including psychotic disorders. This is partly due to the social and economic challenges faced by the population, such as poverty, violence, and social inequality. These factors can increase the risk of developing mental health issues, leading to a higher demand for treatments and medications.Underlying macroeconomic factors also play a role in the growth of the Psychotic Disorders market in Guatemala. The country has been experiencing steady economic growth in recent years, which has led to an increase in disposable income and improved access to healthcare services. As a result, more people are able to afford the necessary treatments and medications for psychotic disorders, contributing to the growth of the market.In conclusion, the Psychotic Disorders market in Guatemala is experiencing significant growth due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The increasing awareness and acceptance of mental health issues, along with the availability of new treatment options, have contributed to the growth of the market. Additionally, the high prevalence of mental health disorders and the country's economic growth have further fueled the demand for treatments and medications for psychotic disorders.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.